Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

The available information suggests that absorption of the test substance will primarily take place in the gastrointestinal tract following oral ingestion. Once absorbed, in all likelihood the substance would be distributed in the serum and excreted via the urine and faeces albeit biliary excretion may be a secondary (minor) route of excretion.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential

Additional information

The absorption, distribution, metabolism and excretion of FAT 36152/M TE have been predicted based on the following information:

FAT 36152/M TE absorption was indicated via the gastro-intestinal tract following oral gavage administration.

FAT 36152/M TE no absorption was indicated via the skin or ocular routes of exposure.

FAT 36152/M TE no uptake via inhalation is anticipated on the basis of the low vapour pressure value and low inhalable particle size which indicated almost all inhaled particles would be cleared in the oral/nasal region and subsequently swallowed with the mucus.

FAT 36152/M TE based on the available evidence including single oral dose and repeated oral dose reproductive screening studies that the test item and/or its predicted metabolites to have limited toxic potential when absorbed through the gastro-intestinal tract.

Excretion of FAT 36152/M TE and any of its predicted metabolites is expected to be from urine and faeces.